slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 66,301-66,330
Pages 3,679
Rows per page 30
Component
66,301-66,330 of 110,355
54
Includes qualitative testimonials from psychiatrists to support the adoption thesis.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
02
The slide uses stacked bar charts to compare AUM vs Base Fees for four different business segments.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Business Model1 hit
03
The slide uses a combination of stacked bar charts and circular indicators for growth rates. The legend distinguishes between Long-term, Cash, Advisory, Institutional Active, and Institutional Index flows.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Business Model1 hit
05
The slide uses a combination of bar charts for repurchases/dividends and a line chart for share counts.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
06
Data sourced from Bloomberg; includes a specific note regarding the BLK Equity Index calculation methodology.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
01
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations 1 hit
03
Uses a before-after-bridge style structure to contrast vaccine efficacy with remaining clinical challenges.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide displays two forest plots showing confidence intervals for vaccine effectiveness across multiple studies.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide describes the mechanism of action for a specific vaccine candidate (BHN97ΔftsY).Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · AgitateLoop · Jobs To Be Done1 hit
07
The slide presents experimental data from a study on live-attenuated pneumococcal vaccines.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The slide presents preclinical data comparing a vaccine candidate (BHN97ΔftsY) against a control (Mock) and a standard (PCV13).Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
The slide presents three sets of survival plots (Kaplan-Meier style) and corresponding bacterial load scatter plots for three different serotype challenges.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
The slide uses bioluminescence imaging to visualize bacterial load in the ear region of mice.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
11
Data presented as scatter plots with horizontal bars indicating means; statistical significance markers included.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
12
The diagram uses question marks to represent the unknown or challenging nature of integrating different protein types into the central platform.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
03
Includes non-GAAP adjustments for notable items.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
04
Includes footnotes referenced as (a) and (b).BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment PerformanceLoop · Cost Of Inaction1 hit
06
Includes a non-GAAP reconciliation note regarding notable items.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
08
Includes footnotes reference to page 12.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
09
Includes footnotes regarding non-GAAP measures and specific reporting units.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
13
The slide presents three distinct sub-tables: total fee revenue impact, impact by line of business for investment services, and total impact to revenue by line of business.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
15
Includes two distinct financial reconciliation tables.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
16
Contains three distinct financial tables: margin reconciliation over time, reconciliation of notable items in 3Q22, and noninterest expense reconciliation.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
01
BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slidesBrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Problem1 hit
02
The chart is a dot plot comparing baseline ALSFRS-R scores across various clinical trials, highlighting NurOwn's lower baseline.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
The slide highlights a subgroup analysis where the treatment effect becomes statistically significant (p=0.050) in the secondary endpoint.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Before After1 hit
05
The slide uses a timeline-based process diagram to explain the clinical trial structure.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
07
The slide outlines the primary endpoint (Clinical Response) and a secondary/supporting metric (piecewise slope) for ALS clinical trials.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
08
The slide details the specific biomarkers used in the study and the exclusion criteria based on missing data.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit